Primary Care Prevention of Stimulant Diversion by High School Students With ADHD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

357 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-13

Study Completion Date

2022-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test clinical strategies that pediatric providers may use to prevent misuse and diversion of stimulants by their adolescent patients with ADHD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

School-Based Depression Prevention for Adolescents With ADHD

NCT04104841

Attention Deficit Hyperactivity Disorder Depressive Symptoms

COMPLETED NA

Stimulant Effects on Disruptive Behavior

NCT03420339

Attention Deficit Hyperactivity Disorder Problem Behavior

RECRUITING PHASE4

Examining Tolerance to CNS Stimulants in ADHD

NCT02039908

Attention-deficit/Hyperactivity Disorder

COMPLETED PHASE4

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

NCT00183391

Attention Deficit Disorder With Hyperactivity

COMPLETED PHASE4

Intervention for Teens With ADHD and Substance Use

NCT02502799

Attention Deficit Hyperactivity Disorder

TERMINATED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study addresses the increase in diversion (selling, sharing, loaning, or trading) of prescription stimulant medications by adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). In the absence of any standardized, empirically evaluated clinical strategies or interventions to prevent or decrease stimulant diversion, this project will test the effect of a brief provider-led intervention for stimulant diversion prevention among adolescents being prescribed stimulant medication in pediatric care. The investigators hypothesize that adolescents treated in pediatric practices randomized to the intervention will report decreased diversion, increased perceived risk of harm, and decreased intentions to divert compared to adolescents treated in pediatric practices randomized to treatment-as-usual. Secondary analyses will examine the effect of the intervention on additional contributing variables (e.g., patient, parent, and provider attitude and behavior change).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ADHD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stimulant Diversion Prevention

Providers will be trained in methods to prevent or decrease the likelihood of stimulant diversion by their adolescent patients (education and counseling, strategies for use by patients and parents, and treatment adjustments).

Group Type ACTIVE_COMPARATOR

Stimulant Diversion Prevention (SDP)

Intervention Type BEHAVIORAL

provider training, patient/parent education and counseling, strategies for use by patients and parents, and treatment adjustments

Treatment As Usual

Standard clinical care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stimulant Diversion Prevention (SDP)

provider training, patient/parent education and counseling, strategies for use by patients and parents, and treatment adjustments

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of ADHD
* Treatment with stimulant medication
* Enrolled in or attending middle school or high school
* Parent/guardian willing to participate
* Receiving treatment at one of the 7 pediatric practices participating in the protocol

Exclusion Criteria

* Not diagnosed with ADHD
* Not treated with stimulant medication
* Not enrolled or attending middle school or high school
* Parent/guardian unwilling to participate
* Not receiving treatment at one of the 7 pediatric practices participating in the protocol

Minimum Eligible Age

13 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No